Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

• Main Authors: Rebecca Zash, MD (Author), Denise L Jacobson, PhD (Author), Modiegi Diseko, BA (Author), Gloria Mayondi, BSc (Author), Mompati Mmalane, MD (Author), Max Essex, ProfPhD (Author), Tendani Gaolethe, MD (Author), Chipo Petlo, BA (Author), Shahin Lockman, MD (Author), Lewis B Holmes, MD (Author), Joseph Makhema, MBBS (Author), Roger L Shapiro, MD (Author)
• Format: Book
• Published: Elsevier, 2018-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Global rollout of dolutegravir-based antiretroviral therapy (ART) has been hampered in part by insufficient safety data in pregnancy. We compared birth outcomes among women initiating dolutegravir-based ART with those among women initiating efavirenz-based ART in pregnancy in Bo...